Table 1 Demographic and clinical characteristics of patients with COPD at the time of admission
All(n = 35)Theophylline(n = 16)Standard therapy(n = 19)
Age (years)67.6 (1.3)66.7 (1.7)68.2 (2.1)
Gender (M/F)35/016/019/0
Smoking (pack-years)58.6 (4.3)62.9 (6.9)54.1 (6.4)
Active smoking, n (%)15 (42%)8 (50%)7 (37%)
Charlson index1.83 (0.2)1.77 (0.3)1.88 (0.2)
FEV1 (l)1.03 (0.1)0.99 (0.1)1.11 (0.1)
FEV1 (%)38.4 (2.1)39.2 (3.8)37.7 (1.9)
FEV1/FVC (%)46.39 (1.9)45.34 (3.3)47.89 (2.7)
Salbutamol reversibility (%)5.17 (1.3)7.33 (1.6)3.89 (1.6)
ICS, n (%)21 (60%)11 (68%)10 (53%)
Pao2 (mm Hg)56.4 (1.6)53.7 (2.4)58.6 (1.7)
Paco2 (mm Hg)45.6 (1.7)48.4 (2.5)42.7 (2.2)
  • Values are mean (SEM) unless indicated otherwise.

  • FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; ICS, inhaled corticosteroids; Pao2, Paco2, arterial oxygen and carbon dioxide tensions.